Your browser doesn't support javascript.
loading
Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis.
Ada, Sibel; Ersan, Sibel; Sifil, Aykut; Unlu, Mehtat; Kolatan, Efsun; Sert, Mehmet; Sarioglu, Sulen; Yilmaz, Osman; Camsari, Taner.
Afiliação
  • Ada S; Division of Nephrology, Department of Internal Medicine, Dokuz Eylul University Hospital, Izmir, Turkey.
  • Ersan S; Division of Nephrology, Department of Internal Medicine, Dokuz Eylul University Hospital, Izmir, Turkey. ersansibel1@gmail.com.
  • Sifil A; Division of Nephrology, Department of Internal Medicine, Dokuz Eylul University Hospital, Izmir, Turkey.
  • Unlu M; Department of Pathology, Dokuz Eylul University Hospital, Izmir, Turkey.
  • Kolatan E; Department of Laboratory Animals Science, Dokuz Eylul University Hospital, Izmir, Turkey.
  • Sert M; Division of Nephrology, Department of Internal Medicine, Dokuz Eylul University Hospital, Izmir, Turkey.
  • Sarioglu S; Department of Pathology, Dokuz Eylul University Hospital, Izmir, Turkey.
  • Yilmaz O; Department of Laboratory Animals Science, Dokuz Eylul University Hospital, Izmir, Turkey.
  • Camsari T; Division of Nephrology, Department of Internal Medicine, Dokuz Eylul University Hospital, Izmir, Turkey.
Int Urol Nephrol ; 47(12): 2047-51, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26433885

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Fibrose Peritoneal / Bevacizumab / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Int Urol Nephrol Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Fibrose Peritoneal / Bevacizumab / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Int Urol Nephrol Ano de publicação: 2015 Tipo de documento: Article